153 related articles for article (PubMed ID: 8228638)
1. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins.
Vilella E; Joven J; Fernández M; Vilaró S; Brunzell JD; Olivecrona T; Bengtsson-Olivecrona G
J Lipid Res; 1993 Sep; 34(9):1555-64. PubMed ID: 8228638
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma lipoproteins with postheparin lipase activities.
Goldberg IJ; Kandel JJ; Blum CB; Ginsberg HN
J Clin Invest; 1986 Dec; 78(6):1523-8. PubMed ID: 3782469
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.
Tornvall P; Olivecrona G; Karpe F; Hamsten A; Olivecrona T
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1086-93. PubMed ID: 7627700
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of LPL and LDL: effects of lipoproteins and anti-apoB antibodies.
Choi SY; Pang L; Kern PA; Kayden HJ; Curtiss LK; Vanni-Reyes TM; Goldberg IJ
J Lipid Res; 1997 Jan; 38(1):77-85. PubMed ID: 9034202
[TBL] [Abstract][Full Text] [Related]
5. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
[TBL] [Abstract][Full Text] [Related]
6. Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities.
Glaser DS; Yost TJ; Eckel RH
J Lipid Res; 1992 Feb; 33(2):209-14. PubMed ID: 1569373
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
Totsuka M; Miyashita Y; Ito Y; Watanabe H; Murano T; Shirai K
Atherosclerosis; 2000 Nov; 153(1):175-9. PubMed ID: 11058713
[TBL] [Abstract][Full Text] [Related]
8. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II.
Kawaguchi A; Miyao Y; Noguchi T; Nonogi H; Yamagishi M; Miyatake K; Kamikubo Y; Kumeda K; Tsushima M; Yamamoto A; Kato H
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):251-8. PubMed ID: 10634826
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
Heeren J; Niemeier A; Merkel M; Beisiegel U
J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
[TBL] [Abstract][Full Text] [Related]
10. Defective enzyme protein in lipoprotein lipase deficiency.
Auwerx JH; Babirak SP; Fujimoto WY; Iverius PH; Brunzell JD
Eur J Clin Invest; 1989 Oct; 19(5):433-7. PubMed ID: 2511019
[TBL] [Abstract][Full Text] [Related]
11. Measurement of the serum lipoprotein lipase concentration is useful for studying triglyceride metabolism: Comparison with postheparin plasma.
Hirano T; Nishioka F; Murakami T
Metabolism; 2004 Apr; 53(4):526-31. PubMed ID: 15045703
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein lipase is active as a monomer.
Beigneux AP; Allan CM; Sandoval NP; Cho GW; Heizer PJ; Jung RS; Stanhope KL; Havel PJ; Birrane G; Meiyappan M; Gill JE; Murakami M; Miyashita K; Nakajima K; Ploug M; Fong LG; Young SG
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6319-6328. PubMed ID: 30850549
[TBL] [Abstract][Full Text] [Related]
13. Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins.
Zambon A; Schmidt I; Beisiegel U; Brunzell JD
J Lipid Res; 1996 Nov; 37(11):2394-404. PubMed ID: 8978491
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
[TBL] [Abstract][Full Text] [Related]
15. The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteins.
Sato K; Okajima F; Miyashita K; Imamura S; Kobayashi J; Stanhope KL; Havel PJ; Machida T; Sumino H; Murakami M; Schaefer E; Nakajima K
Clin Chim Acta; 2016 Oct; 461():114-25. PubMed ID: 27342999
[TBL] [Abstract][Full Text] [Related]
16. Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity.
van Beek AP; van Barlingen HH; de Ruijter-Heijstek FC; Jansen H; Erkelens DW; Dallinga-Thie GM; de Bruin TW
J Lipid Res; 1998 Feb; 39(2):322-32. PubMed ID: 9507993
[TBL] [Abstract][Full Text] [Related]
17. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
[TBL] [Abstract][Full Text] [Related]
18. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans.
Chappell DA; Fry GL; Waknitz MA; Muhonen LE; Pladet MW; Iverius PH; Strickland DK
J Biol Chem; 1993 Jul; 268(19):14168-75. PubMed ID: 8314783
[TBL] [Abstract][Full Text] [Related]
20. Orlistat fails to alter postprandial plasma lipid excursions or plasma lipases in normal-weight male volunteers.
Shepard TY; Jensen DR; Blotner S; Zhi J; Guerciolini R; Pace D; Eckel RH
Int J Obes Relat Metab Disord; 2000 Feb; 24(2):187-94. PubMed ID: 10702769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
